Overall, the study uncovered latent defects in DNA repair of MGMT-expressing melanoma cells exploitable only during MAPK inhibition, as treatment with PARP inhibitor alone was insufficient to exert cytotoxic effects in MGMT-expressing melanomas. Here, MGMT is linked to melanoma.